Factors associated with intensive care admission in patients with lung cancer: a population-based observational study of 26, 731 patients.


Journal

BMC pulmonary medicine
ISSN: 1471-2466
Titre abrégé: BMC Pulm Med
Pays: England
ID NLM: 100968563

Informations de publication

Date de publication:
07 Feb 2020
Historique:
received: 31 07 2019
accepted: 30 01 2020
entrez: 9 2 2020
pubmed: 9 2 2020
medline: 28 11 2020
Statut: epublish

Résumé

Lung cancer is the most common cause of cancer related death worldwide and survival is poor. Patients with lung cancer may develop a critical illness, but it is unclear what features are associated with an Intensive Care Unit (ICU) admission. This retrospective, observational, population-based study of linked cancer registration, ICU, hospital discharge and mortality data described the factors associated with ICU admission in patients with lung cancer. The cohort comprised all incident cases of adult lung cancer diagnosed between 1st January 2000 and 31st December 2009 in the West of Scotland, UK, who were subsequently admitted to an ICU within 2 years of cancer diagnosis. Multiple logistic regression was used to determine factors associated with admission. 26,731 incident cases of lung cancer were diagnosed with 398 (1.5%) patients admitted to an ICU. Patients were most commonly admitted with respiratory conditions and there was a high rate of invasive mechanical ventilation. ICU, in-hospital and six-month survival were 58.5, 42.0 and 31.2%, respectively. Surgical treatment of lung cancer increased the odds of ICU admission (OR 7.23 (5.14-10.2)). Odds of admission to ICU were reduced with older age (75-80 years OR 0.69 (0.49-0.94), > 80 years OR 0.21 (0.12-0.37)), female gender (OR 0.73 (0.59-0.90)) and radiotherapy (OR 0.54 (0.39-0.73)) or chemotherapy treatment (OR 0.52 (0.38-0.70)). 1.5% of patients diagnosed with lung cancer are admitted to an ICU but both short term and long term survival was poor. Factors associated with ICU admission included age < 75 years, male gender and surgical treatment of cancer.

Sections du résumé

BACKGROUND BACKGROUND
Lung cancer is the most common cause of cancer related death worldwide and survival is poor. Patients with lung cancer may develop a critical illness, but it is unclear what features are associated with an Intensive Care Unit (ICU) admission.
METHODS METHODS
This retrospective, observational, population-based study of linked cancer registration, ICU, hospital discharge and mortality data described the factors associated with ICU admission in patients with lung cancer. The cohort comprised all incident cases of adult lung cancer diagnosed between 1st January 2000 and 31st December 2009 in the West of Scotland, UK, who were subsequently admitted to an ICU within 2 years of cancer diagnosis. Multiple logistic regression was used to determine factors associated with admission.
RESULTS RESULTS
26,731 incident cases of lung cancer were diagnosed with 398 (1.5%) patients admitted to an ICU. Patients were most commonly admitted with respiratory conditions and there was a high rate of invasive mechanical ventilation. ICU, in-hospital and six-month survival were 58.5, 42.0 and 31.2%, respectively. Surgical treatment of lung cancer increased the odds of ICU admission (OR 7.23 (5.14-10.2)). Odds of admission to ICU were reduced with older age (75-80 years OR 0.69 (0.49-0.94), > 80 years OR 0.21 (0.12-0.37)), female gender (OR 0.73 (0.59-0.90)) and radiotherapy (OR 0.54 (0.39-0.73)) or chemotherapy treatment (OR 0.52 (0.38-0.70)).
CONCLUSION CONCLUSIONS
1.5% of patients diagnosed with lung cancer are admitted to an ICU but both short term and long term survival was poor. Factors associated with ICU admission included age < 75 years, male gender and surgical treatment of cancer.

Identifiants

pubmed: 32033549
doi: 10.1186/s12890-020-1071-8
pii: 10.1186/s12890-020-1071-8
pmc: PMC7007647
doi:

Types de publication

Journal Article Multicenter Study Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

36

Subventions

Organisme : Cancer Research UK
ID : C47114A / A16662
Pays : United Kingdom

Références

JAMA Oncol. 2015 Nov;1(8):1078-85
pubmed: 26313462
J Clin Epidemiol. 1992 Jun;45(6):613-9
pubmed: 1607900
Intensive Care Med. 2012 Oct;38(10):1654-61
pubmed: 22797350
BMC Cancer. 2011 May 02;11:159
pubmed: 21535895
Lung Cancer. 2012 Sep;77(3):600-4
pubmed: 22709929
J Clin Oncol. 2012 May 10;30(14):1686-91
pubmed: 22473159
Chest. 2008 Jan;133(1):72-8
pubmed: 17989164
Ann Oncol. 2014 Sep;25(9):1829-35
pubmed: 24950981
Chest. 2007 Mar;131(3):840-846
pubmed: 17356101
Crit Care Med. 2001 Nov;29(11):2132-6
pubmed: 11700409
J Cancer Res Clin Oncol. 2018 Apr;144(4):717-723
pubmed: 29362918
Cancer Res Treat. 2019 Jul;51(3):973-981
pubmed: 30309220
Crit Care. 2011 Aug 08;15(4):180
pubmed: 21888682
Int J Cancer. 2015 Mar 1;136(5):E359-86
pubmed: 25220842
Crit Care Med. 2001 Jul;29(7):1303-10
pubmed: 11445675
Crit Care Med. 2017 Oct;45(10):1668-1676
pubmed: 28682838
Hippokratia. 2013 Jan;17(1):60-3
pubmed: 23935346
Intensive Care Med. 2014 Oct;40(10):1409-28
pubmed: 25223853
Med Care. 2005 Nov;43(11):1130-9
pubmed: 16224307

Auteurs

Kathryn Puxty (K)

Academic department of Anaesthesia, Critical Care and Pain, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, UK. kadunne@doctors.net.uk.

Christopher H Grant (CH)

Academic department of Anaesthesia, Critical Care and Pain, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, UK.
Department of Public Health, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, UK.

Philip McLoone (P)

Department of Public Health, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, UK.

Billy Sloan (B)

Department of Public Health, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, UK.

Tara Quasim (T)

Academic department of Anaesthesia, Critical Care and Pain, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, UK.

Kate Hulse (K)

Academic department of Anaesthesia, Critical Care and Pain, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, UK.

David S Morrison (DS)

Department of Public Health, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH